1. Home
  2. Labeler Index
  3. Zydus Lifesciences Limited
  4. 70771-1881
  5. NDC Package Code: 70771-1881-3 Zituvimet Xr

NDC Package 70771-1881-3 Zituvimet Xr

Sitagliptin And Metformin Hydrochloride Tablet, Film Coated, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70771-1881-3
Package Description:
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product Code:
70771-1881
Proprietary Name:
Zituvimet Xr
Non-Proprietary Name:
Sitagliptin And Metformin Hydrochloride
Substance Name:
Metformin Hydrochloride; Sitagliptin
11-Digit NDC Billing Format:
70771188103
NDC to RxNorm Crosswalk:
  • RxCUI: 1243827 - SITagliptin 100 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1243827 - 24 HR metformin hydrochloride 1000 MG / sitagliptin 100 MG Extended Release Oral Tablet
  • RxCUI: 1243827 - metformin hydrochloride 1000 MG / sitagliptin 100 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 1243842 - SITagliptin 50 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1243842 - 24 HR metformin hydrochloride 1000 MG / sitagliptin 50 MG Extended Release Oral Tablet
Product Type:
Human Prescription Drug
Labeler Name:
Zydus Lifesciences Limited
Dosage Form:
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
NDA216778
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
10-31-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70771-1881-3?

The NDC Packaged Code 70771-1881-3 is assigned to a package of 30 tablet, film coated, extended release in 1 bottle of Zituvimet Xr, a human prescription drug labeled by Zydus Lifesciences Limited. The product's dosage form is tablet, film coated, extended release and is administered via oral form.

Is NDC 70771-1881 included in the NDC Directory?

Yes, Zituvimet Xr with product code 70771-1881 is active and included in the NDC Directory. The product was first marketed by Zydus Lifesciences Limited on October 31, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70771-1881-3?

The 11-digit format is 70771188103. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170771-1881-35-4-270771-1881-03